August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Diego A. Díaz-García Highlighted the Results of SUPE_R Trial
Aug 10, 2025, 18:01

Diego A. Díaz-García Highlighted the Results of SUPE_R Trial

Diego A. Díaz-García, Medical Oncologist, CEO, and Founder of CánCare – Advanced Oncology Specialty, shared a post on X about a paper by Kasper Guldbrandsen et al. published in the Journal of Thoracic Oncology:

“SUPE_R trial: In stage I–III NSCLC, [18F]FDG PET/CT vs ceCT after curative treatment showed:
  • Same rate of recurrences treated curatively (48%)
  • More detected via scheduled follow-up (90% vs 77%)
  • No TTR or OS benefit

JTO & JTO CRR.”

Title: Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled Trial

Authors: Kasper Guldbrandsen, Martin Bloch, Kristin Skougaard, Lise Ahlborn, Erik Jakobsen, Anette Højsgaard, Rene Petersen, Lars Møller, Morten Dahl, Boe Sorensen, Malene Frank, Jeanette Ehlers, Martin Krakauer, Peter Gørtz, Elisabeth Albrecht-Beste, Julie Grüner, Zaigham Saghir, Joan Fledelius, Anne Nielsen, Paw Holdgaard, Søren Nielsen, Mette Pøhl, Svetlana Borissova, Lotte Land, Charlotte Kristiansen, Tine McCulloch, Lise Mortensen, Hanne Nellemann, Malene Christophersen, Ole Hilberg, Thor Rasmussen, Signe Schwaner, Christian Laursen, Uffe Bodtger, Liza Sopina, Markus Lonsdale, Christian Meyer, Oke Gerke, Jann Mortensen, Torben Rasmussen, Barbara Fischer.

You can read the Full Article on the Journal of Thoracic Oncology.

Diego A. Díaz-García

More posts featuring Diego A. Díaz-García on OncoDaily.